Table 5.
Other infection | Other infection only | HR-HPV only | HIV only | HR-HPV + HIV | HR-HPV + other | HIV + other | HR-HPV + HIV + other | |
---|---|---|---|---|---|---|---|---|
HSV 2 | OR | NA | 4.99 | NA | 14.3 | 7.85 | NA | 9.89 |
95% CI | 2.27–11.0 | 6.20–33.1 | 2.84–21.7 | 3.85–25.4 | ||||
p | < 0.001 | < 0.001 | < 0.001 | < 0.001 | ||||
n = 447 | n | 11 | 178 | 3 | 88 | 32 | 4 | 42 |
Syphilis | OR | NA | 4.51 | NA | 9.83 | 5.58 | NA | 18.6 |
95% CI | 2.03–10.1 | 4.20–23.0 | 1.33–23.4 | 5.67–61.0 | ||||
p | < 0.001 | < 0.001 | 0.019 | < 0.001 | ||||
n = 358 | n | 3 | 203 | 7 | 109 | 8 | 0 | 21 |
Gonorrhoea | OR | NA | 3.88 | NA | 10.4 | 6.45 | NA | 9.11 |
95% CI | 1.71–8.83 | 4.32–25.0 | 2.32–17.9 | 3.40–24.4 | ||||
p | 0.001 | < 0.001 | < 0.001 | < 0.001 | ||||
n = 355 | n | 9 | 181 | 6 | 95 | 28 | 1 | 35 |
Chlamydia | OR | NA | 3.95 | NA | 10.3 | 4.80 | NA | 7.70 |
95% CI | 1.73–9.02 | 4.39–24.3 | 1.78–13.0 | 2.52–23.5 | ||||
p | < 0.001 | < 0.001 | 0.002 | < 0.001 | ||||
n = 358 | n | 12 | 175 | 5 | 107 | 34 | 2 | 23 |
HBV | OR | NA | 8.25 | NA | 27.7 | NA | NA | 18.2 |
95% CI | 2.90–23.5 | 7.80–98.3 | 3.69–89.9 | |||||
p | < 0.001 | < 0.001 | < 0.001 | |||||
n = 441 | n | 1 | 203 | 7 | 98 | 6 | 7 | 25 |
HCV | OR | NA | 5.66 | NA | 16.3 | NA | NA | |
95% CI | 2.10–15.2 | 5.15–51.9 | ||||||
p | 0.001 | < 0.001 | ||||||
n = 431 | n | 8 | 204 | 7 | 115 | 3 | 0 | 13 |
NA: indicates that there were insufficient cases to permit estimation.
n: the number of samples for whom there was complete data.